SE453497B - Antitumormedel och kompositioner pa basis derav samt forfarande for framstellning av dessa kompositioner - Google Patents

Antitumormedel och kompositioner pa basis derav samt forfarande for framstellning av dessa kompositioner

Info

Publication number
SE453497B
SE453497B SE8100341A SE8100341A SE453497B SE 453497 B SE453497 B SE 453497B SE 8100341 A SE8100341 A SE 8100341A SE 8100341 A SE8100341 A SE 8100341A SE 453497 B SE453497 B SE 453497B
Authority
SE
Sweden
Prior art keywords
amsa
solution
organic acid
gluconolactone
water
Prior art date
Application number
SE8100341A
Other languages
English (en)
Swedish (sv)
Other versions
SE8100341L (sv
Inventor
D Bouzard
C Perol
J Stemer
A Weber
E S Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26812557&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE453497(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8100341L publication Critical patent/SE8100341L/xx
Publication of SE453497B publication Critical patent/SE453497B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8100341A 1980-01-24 1981-01-21 Antitumormedel och kompositioner pa basis derav samt forfarande for framstellning av dessa kompositioner SE453497B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11480980A 1980-01-24 1980-01-24
US06/194,350 US4322424A (en) 1980-01-24 1980-10-17 Crystalline glucoconate salt of m-AMSA and compositions containing same

Publications (2)

Publication Number Publication Date
SE8100341L SE8100341L (sv) 1981-07-25
SE453497B true SE453497B (sv) 1988-02-08

Family

ID=26812557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100341A SE453497B (sv) 1980-01-24 1981-01-21 Antitumormedel och kompositioner pa basis derav samt forfarande for framstellning av dessa kompositioner

Country Status (17)

Country Link
US (1) US4322424A (da)
AT (1) AT380474B (da)
AU (1) AU543758B2 (da)
CA (1) CA1252103A (da)
CH (1) CH648023A5 (da)
DE (1) DE3102026A1 (da)
DK (1) DK29781A (da)
FI (1) FI79840C (da)
FR (1) FR2474493B1 (da)
GB (1) GB2068729B (da)
GR (1) GR82326B (da)
IE (1) IE50884B1 (da)
IT (1) IT1170638B (da)
LU (1) LU83081A1 (da)
NL (1) NL8100292A (da)
SE (1) SE453497B (da)
YU (1) YU42552B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186383B (en) * 1981-02-27 1985-07-29 Biogal Gyogyszergyar Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
US3839344A (en) * 1973-03-28 1974-10-01 Schering Corp N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid
US4258191A (en) * 1979-03-29 1981-03-24 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Multi-step process for the production of methanesulfon-m-anisidide, 4'-(9-acridinylamino)-
ZA805652B (en) * 1979-09-14 1981-09-30 New Zealand Dev Finance Compounds having antitumour properties
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Also Published As

Publication number Publication date
FI79840B (fi) 1989-11-30
IT1170638B (it) 1987-06-03
GR82326B (da) 1984-12-13
GB2068729B (en) 1983-10-19
US4322424A (en) 1982-03-30
SE8100341L (sv) 1981-07-25
YU42552B (en) 1988-10-31
ATA32681A (de) 1985-10-15
IE50884B1 (en) 1986-08-06
DE3102026C2 (da) 1990-05-31
LU83081A1 (fr) 1981-09-10
FR2474493A1 (fr) 1981-07-31
CA1252103A (en) 1989-04-04
DE3102026A1 (de) 1982-03-04
AU543758B2 (en) 1985-05-02
IE810119L (en) 1981-07-24
DK29781A (da) 1981-07-25
IT8147604A0 (it) 1981-01-21
AU6651281A (en) 1981-07-30
IT8147604A1 (it) 1982-07-21
AT380474B (de) 1986-05-26
GB2068729A (en) 1981-08-19
FR2474493B1 (fr) 1985-12-13
FI79840C (fi) 1990-03-12
FI810180L (fi) 1981-07-25
NL8100292A (nl) 1981-08-17
CH648023A5 (de) 1985-02-28
YU14581A (en) 1983-06-30

Similar Documents

Publication Publication Date Title
JP2568401B2 (ja) 水溶性メグルミン塩及びグルカミン塩、その製造方法並びにこれを含有する医薬組成物
TW200944508A (en) Novel solid forms of bendamustine hydrochloride
ES2870614T3 (es) Hemihidrato de la base libre de la N-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)fenil]acetamida, métodos para su fabricación y sus usos
KR880002087B1 (ko) 항균성 나프티리딘 또는 퀴놀린 화합물의 염 및 그의 제조방법
JPH0248526A (ja) インドメタシン注射剤およびその製造方法
JPS6145626B2 (da)
PT91132B (pt) Processo para a preparacao de hidrohaletos de rifapentina
HRP20020231A2 (en) ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA1160571A (en) Antitumor compositions
US4772589A (en) Etoposide solution in NMP
SE453497B (sv) Antitumormedel och kompositioner pa basis derav samt forfarande for framstellning av dessa kompositioner
JP7148642B2 (ja) 安定したアザシチジン含有医薬組成物の製造方法
JP4130700B2 (ja) 抗腫瘍剤含有組成物
JPS6163695A (ja) プリマイシン塩、その製造法および医薬組成物
KR102210848B1 (ko) 3-포르밀리파마이신 sv 및 3-포르밀리파마이신 s의 3-(4-신나밀-1-피페라지닐) 아미노 유도체를 함유하는 제약 제제 및 그의 제조 방법
JPH0343251B2 (da)
JPH032862B2 (da)
NO764182L (da)
US4575509A (en) Water-soluble formulations of m-AMSA with pyroglutamic acid
CA1159368A (en) Antitumor compositions
US2753340A (en) Maleate salts of protoveratrine a and protoveratrine b
JPH0315632B2 (da)
JPS5890587A (ja) イセチオン酸塩
JPS6125039B2 (da)
EP0301465A1 (en) Crystalline monohydrate of sodium N-(1H-tetrazol-5-yl)-1-phenoxy-4H-quinolizin-4-one-3-carboxamide

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8100341-0

Effective date: 19920806

Format of ref document f/p: F